"Huge" Personalized Med Opportunity For Device/Dx Firms - PwC Survey
This article was originally published in The Gray Sheet
Executive SummaryDevice and diagnostics companies stand to benefit from a global health care system that will increasingly lean toward personalized medicine, according to a PricewaterhouseCoopers survey
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.